Audit Standards | Target (%) | Exception | Results | Guidelines |
1) adult patient who are on or recently used high-dose oral or high-dose systemic GC (e.g. more than 7.5 mg prednisolone or equivalent per day for 3 months or longer) should be considered for fracture risk assessment (or BMD testing if patient below 40 years old). | 50% | No | Insufficient information to draw a result. | NICE |
2) Optimizing calcium intake (1000 - 1200 mg/day) For all patients receiving GC treatment. | 50% | Causes of hypercalcemia and allergies to calcium components. | 6.7% | ACR |
3) Optimizing vitamin D intake (600 - 800 IU/day) for all patients receiving GC therapy. | 50% | Causes of hypercalcemia and vitamin D toxicity | Insufficient information to draw a result. | ACR |
4) Optimizing lifestyle modifications (a balanced diet, maintaining weight in the recommended range, smoking cessation, regular weight bearing or resistance training exercise, limiting alcohol intake to 1 - 2 alcoholic beverages/day ) for all patients receiving GC therapy. | 50% | No | 15.6% | ACR |